THE GLIOBLASTOMA FOUNDATION IS DEDICATED TO FINDING A CURE FOR GLIOBLASTOMA BY FUNDING RESEARCH AND DRUG DEVELOPMENT, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS DEVASTATING BRAIN CANCER. THROUGH THESE INTEGRATED PROGRAMS, THE FOUNDATION ACCELERATES SCIENTIFIC DISCOVERY, EMPOWERS PATIENTS WITH INFORMATION AND RESOURCES, AND EDUCATES THE PUBLIC ABOUT THE URGENT NEED FOR BETTER TREATMENTS AND IMPROVED OUTCOMES.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024
Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.
- Base
- $292k
- Bonus
- —
- Other
- —
- Benefits
- $29k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
CEO 75th to 90th percentile | $292k | — | — | $29k | $343k $364k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 4 unpaid individuals.
Top pay as a share of expenses
In 2024, the highest total compensation at GLIOBLASTOMA FOUNDATION INC equaled 19% of the organization's total expenses. The median for medical research organizations is 10%.
Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Up 2%
from 2023
From $336k in 2023 to $343k in 2024.
Estimated with BLS CPI-U for the South region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay rose 2% from 2023 to 2024, while revenue rose 21%.
Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about GLIOBLASTOMA FOUNDATION INC
What does the Chief Executive Officer of GLIOBLASTOMA FOUNDATION INC earn?
In 2024, the Chief Executive Officer of GLIOBLASTOMA FOUNDATION INC received $343,048 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among Medical Research organizations nationwide, though not the top 10% of comparable filings. Based on IRS Form 990 data.
How does Chief Executive Officer pay at GLIOBLASTOMA FOUNDATION INC compare with similar nonprofits?
Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at GLIOBLASTOMA FOUNDATION INC falls between the 75th and 90th percentiles. In 2024, the highest total compensation at GLIOBLASTOMA FOUNDATION INC equaled 19% of the organization's total expenses. The median for medical research organizations is 10%.
What are GLIOBLASTOMA FOUNDATION INC's revenue and expenses?
In 2024, GLIOBLASTOMA FOUNDATION INC reported $2.1M in total revenue and $1.8M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more